LISDEXAMFETAMINE 50 MG CAPSULE

Lisdexamfetamine Dimesylate
$2.7928per EA
DEA Schedule CII

Strength

50 mg/1

Manufacturer

Apotex Corp.

NDC

60505474301

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA216944

On Market Since

11/9/2023

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-1.3%

3M

-6.2%

6M

-17.5%

1Y

-38.3%

3Y

N/A

5Y

N/A

All

-26.1%